Journal
CHINESE JOURNAL OF CANCER
Volume 34, Issue 2, Pages 61-69Publisher
SUN YAT SEN UNIV MED SCI WHO
DOI: 10.5732/cjc.014.10146
Keywords
Receptor-type protein tyrosine phosphatases (PTPRs); cancer; mutation; deletion; amplification; promoter methylation
Categories
Funding
- NCI NIH HHS [R01 CA077308] Funding Source: Medline
Ask authors/readers for more resources
Protein tyrosine phosphatases (PTPs) play an important role in regulating cell signaling events in coordination with tyrosine kinases to control cell proliferation, apoptosis, survival, migration, and invasion. Receptor-type protein tyrosine phosphatases (PTPRs) are a subgroup of PTPs that share a transmembrane domain with resulting similarities in function and target specificity. In this review, we summarize genetic and epigenetic alterations including mutation, deletion, amplification, and promoter methylation of PTPRs in cancer and consider the consequences of PTPR alterations in different types of cancers. We also summarize recent developments using PTPRs as prognostic or predictive biomarkers and/or direct targets. Increased understanding of the role of PTPRs in cancer may provide opportunities to improve therapeutic approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available